Third Rock Ventures GP IV, L.P., 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 330,000 shares at $9.80 ($3.2M) on 2024-07-30, disclosed to the SEC on 2024-08-01.
Open-market sale of $3.2M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.80 | 95,000 | $931K | 28.7% |
| 2 | $9.80 | 95,000 | $931K | 28.7% |
| 3 | $9.93 | 100,000 | $993K | 30.6% |
| 4 | $9.80 | 40,000 | $392K | 12.1% |
| Total | $9.84 avg | 330,000 | $3.2M | 100% |
| Filing → |
| TNGX | SELL | 2024-08-20 | $2.8M | — | Filing → |
| TNGX | SELL | 2024-07-24 | $6.4M | — | Filing → |
| TNGX | SELL | 2024-07-18 | $10.8M | — | Filing → |